Hunan Xinhexin Bio-Pharmaceutical Co., Ltd. announced that it will receive CNY 500,000,000 in an equity round of funding on October 18, 2023. The transaction will include participation from new investor, ZhuZhou QianJin Pharmaceutical Co.,Ltd for CNY 50,000,000 for 1.5870% stake. Through the transaction, the company will increase its registered capital from CNY 480,494,941 to not more than CNY 57,114,034.